Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics
FOLD Price/Volume Stats
| Current price | $8.62 | 52-week high | $12.65 |
| Prev. close | $8.69 | 52-week low | $8.52 |
| Day low | $8.52 | Volume | 3,054,300 |
| Day high | $8.71 | Avg. volume | 2,383,780 |
| 50-day MA | $9.31 | Dividend yield | N/A |
| 200-day MA | $10.23 | Market Cap | 2.65B |
FOLD Stock Price Chart Interactive Chart >
Amicus Therapeutics, Inc. (FOLD) Company Bio
Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.
FOLD Price Returns
| 1-mo | -7.71% |
| 3-mo | -11.77% |
| 6-mo | -19.51% |
| 1-year | -24.58% |
| 3-year | -7.71% |
| 5-year | -3.58% |
| YTD | -8.49% |
| 2024 | -33.62% |
| 2023 | 16.22% |
| 2022 | 5.71% |
| 2021 | -49.98% |
| 2020 | 137.06% |
Continue Researching FOLD
Here are a few links from around the web to help you further your research on Amicus Therapeutics Inc's stock as an investment opportunity:Amicus Therapeutics Inc (FOLD) Stock Price | Nasdaq
Amicus Therapeutics Inc (FOLD) Stock Quote, History and News - Yahoo Finance
Amicus Therapeutics Inc (FOLD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...